Rare Tumor
Aadi TSC-007
Official Title: A phase 2 multi-center open label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes
Study Purpose: To find out more about the safety and effectiveness of nab-sirolimus in adolescents and adults with advanced solid tumors bearing TSC1 or TSC2 inactivating mutation
Status:
Recruiting